Camoxis Therapeutics Limited
14758276
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2025
dormant
Next accounts due
31/12/2026
Confirmation statement
Last: 24/03/2026
Due 07/04/2027
Industry
Officers
director · Since 25/03/2023
CEO
BRITISH · UNITED KINGDOM · Age 37
Also on 2 other boards
Persons with Significant Control
Prof. Thomas Krieg
German · England · Age 58
1 Beauchamp Court, 10 Victors Way, Barnet, EN5 5TZ
Notified 25/03/2023
Mr Mithilan Thayalasingham
British · United Kingdom · Age 37
1 Beauchamp Court, 10 Victors Way, Barnet, EN5 5TZ
Notified 25/03/2023
Michael Patrick Murphy
Irish · United Kingdom · Age 63
1 Beauchamp Court, 10 Victors Way, Barnet, EN5 5TZ
Notified 25/03/2023
CompanyRankvs 6174+ SIC 72190 peers34
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£3
Balance sheet strength
Cash
£3
Cash in the bank
Net Current Assets
£3
Working capital
Current Assets
£3
Current Liabilities
—
Balance Sheet